Difference between right-sided and left-sided colorectal cancers: from embryology to molecular subtype

Seung Yoon Yang, Min Soo Cho, Nam Kyu Kim

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Introduction: Colorectal cancer is one of the most common malignancies in the world, and it exhibits differences in incidence, pathogenesis, molecular pathways, and outcome depending on the location of the tumor. Differences in the microbiome, clinical characteristics, and chromosomal and molecular characteristics have been reported between the right and left side of the colon. Areas covered: This review focuses on the latest developments in epidemiological and chromosomal and molecular studies, which have enhanced our understanding on the underlying genetic and immunological differences between the right-sided colon and the left-sided colorectum in metastatic colorectal cancer. Expert commentary: The numerous findings regarding differences between right- and left-sided colon cancers should have an impact on colorectal cancer screening and therapy. The location of the colorectal cancer should be considered before group stratification into genetic, clinical, and especially chemotherapy trials. A more tailored approach to colon cancer treatment would be highly desirable if future trials further support the hypothesis of two distinct tumor entities.

Original languageEnglish
Pages (from-to)351-358
Number of pages8
JournalExpert Review of Anticancer Therapy
Volume18
Issue number4
DOIs
Publication statusPublished - 2018 Apr 3

Fingerprint

Embryology
Colorectal Neoplasms
Colonic Neoplasms
Colon
Neoplasms
Microbiota
Early Detection of Cancer
Drug Therapy
Incidence
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology
  • Pharmacology (medical)

Cite this

@article{3b6477fea69f4065828c46f3b435324d,
title = "Difference between right-sided and left-sided colorectal cancers: from embryology to molecular subtype",
abstract = "Introduction: Colorectal cancer is one of the most common malignancies in the world, and it exhibits differences in incidence, pathogenesis, molecular pathways, and outcome depending on the location of the tumor. Differences in the microbiome, clinical characteristics, and chromosomal and molecular characteristics have been reported between the right and left side of the colon. Areas covered: This review focuses on the latest developments in epidemiological and chromosomal and molecular studies, which have enhanced our understanding on the underlying genetic and immunological differences between the right-sided colon and the left-sided colorectum in metastatic colorectal cancer. Expert commentary: The numerous findings regarding differences between right- and left-sided colon cancers should have an impact on colorectal cancer screening and therapy. The location of the colorectal cancer should be considered before group stratification into genetic, clinical, and especially chemotherapy trials. A more tailored approach to colon cancer treatment would be highly desirable if future trials further support the hypothesis of two distinct tumor entities.",
author = "Yang, {Seung Yoon} and Cho, {Min Soo} and Kim, {Nam Kyu}",
year = "2018",
month = "4",
day = "3",
doi = "10.1080/14737140.2018.1442217",
language = "English",
volume = "18",
pages = "351--358",
journal = "Expert Review of Anticancer Therapy",
issn = "1473-7140",
publisher = "Expert Reviews Ltd.",
number = "4",

}

Difference between right-sided and left-sided colorectal cancers : from embryology to molecular subtype. / Yang, Seung Yoon; Cho, Min Soo; Kim, Nam Kyu.

In: Expert Review of Anticancer Therapy, Vol. 18, No. 4, 03.04.2018, p. 351-358.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Difference between right-sided and left-sided colorectal cancers

T2 - from embryology to molecular subtype

AU - Yang, Seung Yoon

AU - Cho, Min Soo

AU - Kim, Nam Kyu

PY - 2018/4/3

Y1 - 2018/4/3

N2 - Introduction: Colorectal cancer is one of the most common malignancies in the world, and it exhibits differences in incidence, pathogenesis, molecular pathways, and outcome depending on the location of the tumor. Differences in the microbiome, clinical characteristics, and chromosomal and molecular characteristics have been reported between the right and left side of the colon. Areas covered: This review focuses on the latest developments in epidemiological and chromosomal and molecular studies, which have enhanced our understanding on the underlying genetic and immunological differences between the right-sided colon and the left-sided colorectum in metastatic colorectal cancer. Expert commentary: The numerous findings regarding differences between right- and left-sided colon cancers should have an impact on colorectal cancer screening and therapy. The location of the colorectal cancer should be considered before group stratification into genetic, clinical, and especially chemotherapy trials. A more tailored approach to colon cancer treatment would be highly desirable if future trials further support the hypothesis of two distinct tumor entities.

AB - Introduction: Colorectal cancer is one of the most common malignancies in the world, and it exhibits differences in incidence, pathogenesis, molecular pathways, and outcome depending on the location of the tumor. Differences in the microbiome, clinical characteristics, and chromosomal and molecular characteristics have been reported between the right and left side of the colon. Areas covered: This review focuses on the latest developments in epidemiological and chromosomal and molecular studies, which have enhanced our understanding on the underlying genetic and immunological differences between the right-sided colon and the left-sided colorectum in metastatic colorectal cancer. Expert commentary: The numerous findings regarding differences between right- and left-sided colon cancers should have an impact on colorectal cancer screening and therapy. The location of the colorectal cancer should be considered before group stratification into genetic, clinical, and especially chemotherapy trials. A more tailored approach to colon cancer treatment would be highly desirable if future trials further support the hypothesis of two distinct tumor entities.

UR - http://www.scopus.com/inward/record.url?scp=85044052572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044052572&partnerID=8YFLogxK

U2 - 10.1080/14737140.2018.1442217

DO - 10.1080/14737140.2018.1442217

M3 - Review article

C2 - 29458272

AN - SCOPUS:85044052572

VL - 18

SP - 351

EP - 358

JO - Expert Review of Anticancer Therapy

JF - Expert Review of Anticancer Therapy

SN - 1473-7140

IS - 4

ER -